The DOI matches its Crossref record; 265 of the 271 references it cites were found in a registry or an index; 87 of the 187 sources its claims cite were checked for support.
Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer
Open accessAbstract
Brain-derived neurotrophic factor (BDNF) is one of the most distributed and extensively studied neurotrophins in the mammalian brain. BDNF signals through the tropomycin receptor kinase B (TrkB) and the low affinity p75 neurotrophin receptor (p75NTR). BDNF plays an important role in proper growth, development, and plasticity of glutamatergic and GABAergic synapses and through modulation of neuronal differentiation, it influences serotonergic and dopaminergic neurotransmission. BDNF acts as paracrine and autocrine factor, on both pre-synaptic and post-synaptic target sites. It is crucial in the transformation of synaptic activity into long-term synaptic memories. BDNF is considered an instructive mediator of functional and structural plasticity in the central nervous system (CNS), influencing dendritic spines and, at least in the hippocampus, the adult neurogenesis. Changes in the rate of adult neurogenesis and in spine density can influence several forms of learning and memory and can contribute to depression-like behaviors. The possible roles of BDNF in neuronal plasticity highlighted in this review focus on the effect of antidepressant therapies on BDNF-mediated plasticity. Moreover, we will review data that illustrate the role of BDNF as a potent protective factor that is able to confer protection against neurodegeneration, in particular in Alzheimer's disease. Finally, we will give evidence of how the involvement of BDNF in the pathogenesis of brain glioblastoma has emerged, thus opening new avenues for the treatment of this deadly cancer.
Overview
CoChat Summary
TL;DR
This review summarizes BDNF signaling through TrkB and p75NTR and its roles in synaptic plasticity, adult neurogenesis, depression, neurodegeneration, and glioblastoma. It argues that BDNF is a key mediator of antidepressant and exercise effects and a potential therapeutic target, though clinical translation remains uncertain.
Key findings
- BDNF is synthesized as preproBDNF (32–35 kDa), cleaved to proBDNF (28–32 kDa), then mature mBDNF (13 kDa); proBDNF and mBDNF can exert opposing effects via p75NTR and TrkB, respectively.
- The human BDNF gene has 11 exons and nine alternative promoters; the Val66Met polymorphism (rs6265) impairs activity-dependent BDNF secretion and has been linked to mood disorders, cognitive/neurodegenerative phenotypes, but replication is inconsistent.
- In major depressive disorder, BDNF mRNA and protein are decreased in hippocampus, prefrontal cortex, and amygdala; antidepressants increase BDNF/TrkB signaling in rodent cortex and hippocampus. Three months of aerobic exercise training increased hippocampal volume by 12% in healthy individuals and 16% in patients with schizophrenia.
- In Alzheimer’s disease, BDNF is reduced and can correlate with disease severity; mouse studies indicate exercise-induced protection requires both adult hippocampal neurogenesis and BDNF. In glioblastoma, BDNF/TrkB can promote tumor growth, but enriched environment/BDNF can also be oncolytic via IL-15/IFN-γ and TrkB.T1.
Methods
- Narrative review; no primary experiments. It synthesizes published literature on BDNF gene structure, transcripts, miRNAs, signaling, Val66Met, depression, neurodegeneration, and brain cancer.
- Evidence discussed includes rodent models, in vitro cell studies, human postmortem brain tissue, serum/platelet BDNF measures, genetic association studies, and meta-analyses.
- No systematic search strategy, inclusion criteria, or quantitative synthesis is reported.
Limitations
- The paper states that human neuroplasticity remains largely indirect because of methodological limitations and ethical constraints, and that there is no evidence that serum BDNF is related to brain BDNF and neuroplasticity.
- The paper states that Val66Met genetic findings are inconsistent, with failed replications possibly due to environmental factors, ethnicity, age, and sex.
- Evident from the text: as a narrative review, it lacks systematic search and quality appraisal; many mechanistic claims rely on rodent or in vitro models, and causal direction in human disease remains uncertain.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
59 Valid · 7 Not valid · 51 Not checked · 18 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“BDNF protein is also detectable outside of the nervous system in several non-neuronal tissues, such as in endothelial cells [17,18], cardiomyocytes [19], vascular smooth muscle cells [17], leukocytes [20], platelets [21,22], and megakaryocytes [19].”
§ Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer > 1. Introduction
What the sources say
- Not checked yetcites [17] Nakahashi, 2000, Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor, FEBS Lett. source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked — no full text of the sourcecites [18] Wang, 2006, Secretion of brain-derived neurotrophic factor from brain microvascular endothelial cells, Eur. J. Neurosci. source
- Not checked — no full text of the sourcecites [19] 2017, BDNF-A key player in cardiovascular system, J. Mol. Cell. Cardiol. source
- Partly supportedcites [20] Anders, 2020, BDNF mRNA Expression in Leukocytes and Frontal Cortex Function in Drug Use Disorder, Front. Psychiatry sourceExperimental — accuracy not yet measured
Citation [20] is attached specifically to leukocytes. The Methods and Discussion (pages not provided) report BDNF mRNA expression in peripheral-blood leukocytes, but the paper measures RNA rather than demonstrating that BDNF protein is detectable in those cells. The other cell types have separate citations and are not assessed here. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not checked yet
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Several lines of evidence also suggest that the BDNF/TrkB signaling is involved in adult neurogenesis in the hippocampus with differing effects in the dentate gyrus (DG) and subventricular zone (SVZ) [5].”
§ Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer > 1. Introduction
What the sources say
- Partly supportedcites [5] Vilar, 2016, Regulation of Neurogenesis by Neurotrophins during Adulthood: Expected and Unexpected Roles, Front. Neurosci. sourceExperimental — accuracy not yet measured
The section on the SGZ says BDNF/TrkB is important for adult hippocampal neurogenesis, while the section on the SVZ describes different, mixed effects on SVZ proliferation and olfactory-bulb neurogenesis. The claim is imprecise in placing both the dentate gyrus and SVZ within the hippocampus; the paper treats them as distinct neurogenic niches. No page numbers were supplied for these passages. (LLM, conf=0.87)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The functionality of BDNF Val66Met variant was only confirmed in 2003 [112], where BDNF Val66Met polymorphism was shown to disrupt the episodic memory in humans.”
§ Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer > 2. The Human BDNF Gene: Transcripts and Variants > 2.4. The Human BDNF Variant Val66Met
What the sources say
- Supportedcites [112] Egan, 2003, The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function, Cell source
The Results report that met/met subjects scored lower on a test of verbal episodic memory, with a significant effect of BDNF genotype in both controls and the full cohort. The Discussion concludes that the polymorphism has significant effects on human verbal episodic memory. This supports the claim that Val66Met impairs episodic memory in humans. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The pro-domain of BDNF is the locus of a functional human BDNF polymorphism (SNPs) Val66Met, also known as rs6265 or G196Apolymorphism [109].”
§ Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer > 2. The Human BDNF Gene: Transcripts and Variants > 2.4. The Human BDNF Variant Val66Met
What the sources say
- Partly supportedcites [109] Petryshen, 2010, Population genetic study of the brain-derived neurotrophic factor (BDNF) gene, Mol. Psychiatry sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) places Val66Met at position 66 of the proBDNF protein and describes its role in neuronal and cognitive function. Results > Global diversity of BDNF SNPs (page unavailable) identifies Val66Met as rs6265. Our copy does not identify it as G196A or explicitly locate it in the pro-domain, so those details remain unsupported by this source. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“mBDNF-TrkB-signaling pathways regulate multiple events, such as apoptosis and survival of neurons [90,91,92], dendritic growth [93,94,95,96], spine maturation and stabilization, development of synapses [96,97,98], learning- and memory-processes-dependent synaptic plasticity [99,100].”
§ Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer > 2. The Human BDNF Gene: Transcripts and Variants > 2.3. Biology of BDNF
What the sources say
- Partly supportedcites [90] Patel, 2010, BDNF is required for the survival of differentiated geniculate ganglion neurons, Dev. Biol. sourceExperimental — accuracy not yet measured
This source is cited for the apoptosis and neuronal-survival portion of the sentence, not the later claims about dendrites, synapses, or plasticity. The Discussion reports that BDNF prevents death of differentiated geniculate ganglion neurons by suppressing Bax-dependent cell death, and links BDNF loss to increased activated caspase-3. Our copy does not establish that this effect specifically involves mature BDNF–TrkB signaling. (LLM, conf=0.82)
- Not checked yetcites [91] Chen, 2013, Neuroprotective effect of human placenta-derived cell treatment of stroke in rats, Cell Transplant. source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked — no full text of the sourcecites [92] Wu, 2019, Distinct Impacts of Fullerene on Cognitive Functions of Dementia vs. Non-dementia Mice, Neurotox. Res. source
- Supportedcites [93] Gorski, 2003, Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites, J. Neurosci. source
This source is cited in the group attached to dendritic growth, not the separately cited claims about neuronal survival or learning and memory. Its Introduction states that BDNF and TrkB signaling can influence cortical dendrite growth, and the section ‘BDNF is required for maintenance of neuronal morphology’ reports a requirement for BDNF in maintaining cortical dendritic structure. Page numbers are unavailable in our copy. (LLM, conf=0.91)
- Supportedcites [94] Kwon, 2011, BDNF-promoted increases in proximal dendrites occur via CREB-dependent transcriptional regulation of cypin, J. Neurosci. source
This source supports the dendritic-growth portion of the sentence, rather than the separately cited claims about survival or learning and memory. The Introduction describes BDNF as a regulator of dendrite outgrowth and branching, and the Discussion reports BDNF-dependent increases in proximal dendrite number in hippocampal neurons. (LLM, conf=0.91)
- Partly supportedcites [95] Orefice, 2013, Distinct roles for somatically and dendritically synthesized brain-derived neurotrophic factor in morphogenesis of dendritic spines, J. Neurosci. sourceExperimental — accuracy not yet measured
The Introduction and Discussion report that BDNF synthesized in dendrites regulates spine maturation and pruning, and the section on corresponding synaptic changes reports effects on excitatory synapse number and size. Those findings support the spine-maturation and synapse-development portions associated with this citation. Our copy does not establish dendritic growth or spine stabilization, or identify TrkB signaling as the mechanism for these effects; the citations attached to apoptosis and learning-dependent plasticity are different references. (LLM, conf=0.86)
- Supportedcites [96] Zagrebelsky, M., Tacke, C., and Korte, M. (2020). BDNF signaling during the lifetime of dendritic spines. Cell Tissue Res. source
This source is cited for dendritic growth and for spine maturation, stabilization, and synapse development, rather than for the separately cited claims about neuronal survival and learning. The Introduction describes BDNF signaling in spine formation and maintenance, and “Dendritic spine maturation and stabilization” explicitly says maturation depends on TrkB signaling. The review also reports TrkB-related regulation of dendritic morphology; because spines form the postsynaptic part of most excitatory synapses, its account of spine formation supports the synapse-development point. (LLM, conf=0.86)
- Could not verifycites [99] Opazo, 2003, Phosphatidylinositol 3-kinase regulates the induction of long-term potentiation through extracellular signal-related kinase-independent mechanisms, J. Neurosci. sourceExperimental — accuracy not yet measured
The Introduction discusses Ras, PI3-kinase and MAPK signaling in long-term potentiation, but does not connect those findings to mBDNF–TrkB signaling. Searches of our copy for BDNF and TrkB found no passage addressing whether that pathway regulates learning- or memory-related synaptic plasticity. (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [100] Leal, 2017, BDNF and Hippocampal Synaptic Plasticity, Vitam. Horm. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
75 more claims · 23 with their cited sources checked
Create a free account to see all 135 claims and to verify the 25 references still open.
- It may state two separate claims as one. 47
- Probably not a substantial claim. 14
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., et al. (2012) · Nature · doi:10.1038/nature10777 · Cited by 4,810
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599
Trk Receptors: Roles in Neuronal Signal Transduction
Huang, E. J., & Reichardt, L. F. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161629 · Cited by 2,537
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
Paoletti, P., Bellone, C., & Zhou, Q. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3504 · Cited by 2,523
Neurotrophin-regulated signalling pathways
Reichardt, L. F. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.1894 · Cited by 2,195
Cited by
Neuroinflammation, memory, and depression: new approaches to hippocampal neurogenesis
Wu, A., & Zhang, J. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02964-x · Cited by 306
The Potential Health Benefits of Gallic Acid: Therapeutic and Food Applications
Hadidi, M., Liñán-Atero, R., Tarahi, M., Christodoulou, M. C., & Aghababaei, F. (2024) · Antioxidants · doi:10.3390/antiox13081001 · Cited by 263
Azman, K. F., & Zakaria, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126827 · Cited by 221
Intranasal delivery of BDNF-loaded small extracellular vesicles for cerebral ischemia therapy
Zhou, X., Deng, X., Liu, M., He, M., Long, W., Xu, Z., Zhang, K., Liu, T., So, K., Fu, Q., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.03.033 · Cited by 168
TrkB/BDNF signaling pathway and its small molecular agonists in CNS injury
Wang, Y., Liang, J., Xu, B., Yang, J., Wu, Z., & Cheng, L. (2024) · Life Sciences · doi:10.1016/j.lfs.2023.122282 · Cited by 152
Metadata
- Authors
- Colucci-D’Amato, L., Speranza, L., & Volpicelli, F.
- Affiliations
- University of Campania "Luigi Vanvitelli" (IT)
- Albert Einstein College of Medicine (US)
- University of Naples Federico II (IT)
- Corresponding author
- Colucci-D’Amato, Luca
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-10-21
- Volume
- 21
- Issue
- 20
- Pages
- 7777
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7589016
- OpenAlex
- W3094053673
- Semantic Scholar
- b708532c0091c2277fb96a67cf47858ee098c33a
- Cited by
- 991
- References
- 271
- Citations by year
- 2026: 149 · 2025: 251 · 2024: 230 · 2023: 187 · 2022: 122 · 2021: 49 · 2020: 3
- FWCI
- 12.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- brain-derived neurotrophic factor, TrkB receptor, p75 neurotrophin receptor, neuroplasticity, synaptic plasticity, dendritic spines, adult neurogenesis, hippocampus, depression, antidepressant treatment, neurodegeneration, Alzheimer's disease, glioblastoma, neuroprotection, learning and memory
- MeSH terms
- Animals, Antidepressive Agents, Brain Neoplasms, Depression, Humans, Neuronal Plasticity, Oncogenes, Genes, Tumor Suppressor, Neuroprotective Agents, Brain-Derived Neurotrophic Factor, Neurodegenerative Diseases, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer. https://app.cochat.ai/papers/10.3390/ijms21207777
- The paper
- Colucci-D’Amato, L., Speranza, L., & Volpicelli, F. (2020). Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms21207777
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.